Reports related to this article:
Pharmaceuticals company Boehringer Ingelheim expects to invest more than $50 million in its Xochimilco plant in Mexico, with the aim of increasing and improving production by its diabetes segment in the next three years. The company also plans to invest $25 million in its veterinary products plant in Guadalajara, with an expansion to be completed in 2021.
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Explore Our EnergyLive Tools
EnergyLive Tools provide instant insight into new build, outages, maintenance, and capacity shifts across key energy sectors.
Explore Our Tools
Explore Our Enery Industry Reports
Gain the competitive edge with IIR Energy’s suite of energy market reports, designed for traders, analysts, and asset managers who rely on verified, real-time data.
View ReportsIndustry Intel
-
Latin America Data Center Outlook 2026: Power, Hubs & GrowthPodcast Episode / Oct 9, 2026
-
Food and Beverage CapEx Outlook 2026: Tariffs, AI, AfricaPodcast Episode / Oct 9, 2026
-
North America Refining 2026: New Pipelines to PADD 5Podcast Episode / Oct 2, 2026
-
Biomanufacturing Onshoring 2026: GLP-1, CDMO and ReshoringPodcast Episode / Oct 2, 2026
-
2026 US Data Center Outlook: Power, Land & CoolingPodcast Episode / Sep 18, 2026